Cross Fire: BTK Inhibitors Alone or in Combination are the Best Frontline Therapy for CLL
BTK (Bruton's tyrosine kinase) inhibitors are highly effective front-line therapy for CLL (chronic lymphocytic leukemia) due to high response rates and prolonged progression-free survival, even in patients with high-risk disease features. They are also generally well tolerated, with the newer BTK in...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2023-10-01
|
| Col·lecció: | Hematology/Oncology and Stem Cell Therapy |
| Matèries: | |
| Accés en línia: | https://journals.lww.com/10.56875/2589-0646.1040 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|